Preparation method and application of metformin carbon dots

A metformin carbon dot and metformin technology, which is applied to medical preparations containing active ingredients, pharmaceutical formulations, carbon active ingredients, etc., can solve the problems of low functional neuron efficiency, limiting the wide application of neural stem cells, and decreasing neural stem cell survival rate. , to achieve the effect of promoting efficiency and maturity

Pending Publication Date: 2022-08-02
JILIN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the pathological microenvironment leads to a decrease in the survival rate of neural stem cells, and the low efficiency of neural stem cells to differentiate into functional neurons after transplantation in vivo limits the wide application of neural stem cells in transplantation therapy.
Metformin, as a first-line drug for the treatment of diabetes, has been proven to promote the proliferation of neural stem cells in vivo, promote neuron differentiation and axon growth, and establish functional synaptic connections. Because small molecule drugs are easily excreted from the outside of the cell, it can be used in stem cell transplantation. The effect in the weakens with the passage of time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of metformin carbon dots
  • Preparation method and application of metformin carbon dots
  • Preparation method and application of metformin carbon dots

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. The embodiments listed in the present invention are only used to illustrate the present invention, but not to limit the scope of the present invention. Any obvious modifications or changes made to the present invention do not depart from the spirit and scope of the present invention.

[0027] In one embodiment, a method for preparing metformin carbon dots is provided. The method includes the following steps: dissolving 33.124 mg of metformin hydrochloride (molecular weight=165.62 g / mol) and 0.1M citric acid (molecular weight=192.12 g / mol) in 10mL deionized water, ultrasonic for 10min;

[0028] Then CMCDs were synthesized by hydrothermal synthesis: the mixed solution of the two was transferred to a 50 mL autoclave system, and heated at 180 °C for ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method and application of metformin carbon dots, and relates to the technical field of medicine preparation, the method comprises the following steps: S1, respectively dissolving metformin hydrochloride and citric acid in deionized water; s2, transferring the two mixed solutions into a high-pressure reaction kettle system; after the reaction is finished, taking out a reaction system, cooling to room temperature, and collecting to obtain a reaction solution; s3, filtering the reaction solution by adopting a filter membrane, and collecting to obtain filtrate; and S4, removing unreacted small molecular compounds from the filtrate in the step S3 by using a dialysis bag with the molecular weight cut-off of 500Da, and finally freeze-drying to obtain a metformin carbon dot freeze-dried sample. In the preparation process of the metformin carbon dots, the basic pharmacodynamic structure of functional small molecules is not damaged, and the pharmacological activity of the functional small molecules can still be reserved, so that the metformin carbon dots can promote neural stem cells to differentiate into neuronal cells, and compared with metformin, citric acid and a mixture of the metformin and the citric acid which have the same concentration in theory, the metformin carbon dots have a better neuronal differentiation promoting proportion.

Description

technical field [0001] The invention relates to the technical field of drug preparation, in particular to a preparation method and application of metformin carbon dots. Background technique [0002] Neural stem cells can be functionally integrated into neural circuits during the process of differentiation into neurons, thereby achieving functional nerve regeneration. This feature of neural stem cells is expected to become the first choice in the treatment of most neuropathy. However, the pathological microenvironment leads to a decrease in the survival rate of neural stem cells, and the low efficiency of neural stem cells differentiation into functional neurons after transplantation in vivo limits the wide application of neural stem cells in transplantation therapy. As a first-line drug for the treatment of diabetes, metformin has been proven to promote the proliferation of neural stem cells in vivo, promote neuronal differentiation and axonal growth to establish functional...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/155A61K31/194A61K33/44A61K35/30A61P25/00
CPCA61K31/155A61K31/194A61K33/44A61K35/30A61P25/00A61K2300/00
Inventor 陈立张明张静邵丹
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products